• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

高水平的可溶性凝集素样氧化型低密度脂蛋白受体-1 与颈动脉斑块炎症和缺血性卒中风险增加相关。

High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke.

机构信息

1 Center for Medical Imaging and Physiology Skåne University Hospital Lund University Lund Sweden.

2 Experimental Cardiovascular Research Unit Clinical Research Center Clinical Sciences Malmö Lund University Malmö Sweden.

出版信息

J Am Heart Assoc. 2019 Feb 19;8(4):e009874. doi: 10.1161/JAHA.118.009874.

DOI:10.1161/JAHA.118.009874
PMID:30744454
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6405674/
Abstract

Background When the lectinlike oxidized low-density lipoprotein (ox LDL) receptor-1 ( LOX -1), a scavenger receptor for ox LDL , binds ox LDL , processes leading to endothelial dysfunction and inflammation are promoted. We aimed to study release mechanisms of LOX -1 and how circulating levels of soluble LOX -1 ( sLOX -1) relate to plaque inflammation and future risk for ischemic stroke. Methods and Results Endothelial cells and leukocytes were used to study release of sLOX -1. Plasma levels of sLOX -1 were determined in 4703 participants in the Malmö Diet and Cancer cohort. Incidence of ischemic stroke was monitored. For 202 patients undergoing carotid endarterectomy, levels of sLOX -1 were analyzed in plasma and plaque homogenates and related to plaque inflammation factors. Endothelial cells released sLOX -1 when exposed to ox LDL . A total of 257 subjects experienced stroke during a mean follow-up of 16.5 years. Subjects in the highest tertile of sLOX -1 had a stroke hazard ratio of 1.75 (95% CI, 1.28-2.39) compared with those in the lowest tertile after adjusting for age and sex. The patients undergoing carotid endarterectomy had a significant association between plasma sLOX -1 and the plaque content of sLOX -1 ( r=0.209, P=0.004). Plaques with high levels of sLOX -1 had more ox LDL , proinflammatory cytokines, and matrix metalloproteinases. Conclusions Our findings demonstrate that ox LDL induces the release of sLOX -1 from endothelial cells and that circulating levels of sLOX -1 correlate with carotid plaque inflammation and risk for ischemic stroke. These observations provide clinical support to experimental studies implicating LOX -1 in atherosclerosis and its possible role as target for cardiovascular intervention.

摘要

背景

当凝集素样氧化低密度脂蛋白(ox LDL)受体-1(LOX-1),一种氧化 LDL 的清道夫受体,与 ox LDL 结合时,会促进内皮功能障碍和炎症的发生。我们旨在研究 LOX-1 的释放机制以及循环可溶性 LOX-1(sLOX-1)水平与斑块炎症和未来缺血性卒中风险的关系。

方法和结果

使用内皮细胞和白细胞研究 sLOX-1 的释放。在 Malmö Diet and Cancer 队列的 4703 名参与者中测定了 sLOX-1 的血浆水平。监测缺血性卒中的发生。对 202 例行颈动脉内膜切除术的患者,分析了血浆和斑块匀浆中 sLOX-1 的水平,并与斑块炎症因子相关。当暴露于 ox LDL 时,内皮细胞释放 sLOX-1。在平均随访 16.5 年期间,共有 257 名受试者发生卒中。在调整年龄和性别后,sLOX-1 最高三分位组的卒中风险比为 1.75(95%CI,1.28-2.39)。颈动脉内膜切除术患者的血浆 sLOX-1 与斑块中 sLOX-1 的含量之间存在显著相关性(r=0.209,P=0.004)。sLOX-1 水平高的斑块具有更多的 ox LDL、促炎细胞因子和基质金属蛋白酶。

结论

我们的研究结果表明,ox LDL 诱导内皮细胞释放 sLOX-1,而循环 sLOX-1 水平与颈动脉斑块炎症和缺血性卒中风险相关。这些观察结果为实验研究提供了临床支持,表明 LOX-1 在动脉粥样硬化及其作为心血管干预靶点的可能作用中具有重要作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54be/6405674/94aaa664b58d/JAH3-8-e009874-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54be/6405674/823502924256/JAH3-8-e009874-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54be/6405674/15153cd75972/JAH3-8-e009874-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54be/6405674/6958755d0cc3/JAH3-8-e009874-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54be/6405674/94aaa664b58d/JAH3-8-e009874-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54be/6405674/823502924256/JAH3-8-e009874-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54be/6405674/15153cd75972/JAH3-8-e009874-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54be/6405674/6958755d0cc3/JAH3-8-e009874-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/54be/6405674/94aaa664b58d/JAH3-8-e009874-g004.jpg

相似文献

1
High Levels of Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 Are Associated With Carotid Plaque Inflammation and Increased Risk of Ischemic Stroke.高水平的可溶性凝集素样氧化型低密度脂蛋白受体-1 与颈动脉斑块炎症和缺血性卒中风险增加相关。
J Am Heart Assoc. 2019 Feb 19;8(4):e009874. doi: 10.1161/JAHA.118.009874.
2
Increased Levels of Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Ischemic Stroke and Transient Ischemic Attack.缺血性卒中和短暂性脑缺血发作中凝集素样氧化型低密度脂蛋白受体-1水平升高。
J Am Heart Assoc. 2018 Jan 12;7(2):e006479. doi: 10.1161/JAHA.117.006479.
3
Association Between Soluble Lectinlike Oxidized Low-Density Lipoprotein Receptor-1 and Coronary Artery Disease in Psoriasis.银屑病患者可溶性凝集素样氧化型低密度脂蛋白受体-1 与冠状动脉疾病的关系。
JAMA Dermatol. 2020 Feb 1;156(2):151-157. doi: 10.1001/jamadermatol.2019.3595.
4
Relationship of Soluble Lectin-Like Low-Density Lipoprotein Receptor-1 (sLOX-1) With Inflammation and Coronary Plaque Progression in Psoriasis.银屑病患者可溶性凝集素样低密度脂蛋白受体-1(sLOX-1)与炎症及冠状动脉斑块进展的关系。
J Am Heart Assoc. 2023 Nov 21;12(22):e031227. doi: 10.1161/JAHA.123.031227. Epub 2023 Nov 20.
5
LOX-1 in atherosclerotic disease.LOX-1 在动脉粥样硬化疾病中的作用。
Clin Chim Acta. 2015 Feb 2;440:157-63. doi: 10.1016/j.cca.2014.11.016. Epub 2014 Nov 22.
6
Eosinophil Cationic Protein, Carotid Plaque, and Incidence of Stroke.嗜酸性粒细胞阳离子蛋白、颈动脉斑块与卒中发病风险。
Stroke. 2017 Oct;48(10):2686-2692. doi: 10.1161/STROKEAHA.117.018450. Epub 2017 Sep 13.
7
Cadmium, Carotid Atherosclerosis, and Incidence of Ischemic Stroke.镉、颈动脉粥样硬化与缺血性脑卒中的发生。
J Am Heart Assoc. 2017 Dec 2;6(12):e006415. doi: 10.1161/JAHA.117.006415.
8
Elevated soluble LOX-1 predicts risk of first-time myocardial infarction.可溶性 LOX-1 水平升高预示首次心肌梗死的风险。
Ann Med. 2023;55(2):2296552. doi: 10.1080/07853890.2023.2296552. Epub 2023 Dec 22.
9
Soluble lectin-like oxidized low-density lipoprotein receptor-1 as a novel biomarker for large-artery atherosclerotic stroke.可溶性凝集素样氧化型低密度脂蛋白受体-1作为大动脉粥样硬化性卒中的新型生物标志物。
Int J Neurosci. 2017 Oct;127(10):881-886. doi: 10.1080/00207454.2016.1272601. Epub 2017 Jan 4.
10
Serum Levels of Carbamylated LDL and Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Are Associated with Coronary Artery Disease in Patients with Metabolic Syndrome.血清中氨甲酰化 LDL 和可溶性凝集素样氧化型低密度脂蛋白受体-1 水平与代谢综合征患者的冠状动脉疾病相关。
Medicina (Kaunas). 2019 Aug 15;55(8):493. doi: 10.3390/medicina55080493.

引用本文的文献

1
Novel cardiac biomarkers and multiple-marker approach in the early detection, prognosis, and risk stratification of cardiac diseases.新型心脏生物标志物及多标志物方法在心脏病早期检测、预后评估及风险分层中的应用
World J Cardiol. 2025 Jul 26;17(7):106561. doi: 10.4330/wjc.v17.i7.106561.
2
Prognostic Value of Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 for Future Cardiovascular Disease Risk and Outcome: A Systematic Review and Meta-Analysis.凝集素样氧化型低密度脂蛋白受体-1对未来心血管疾病风险和预后的预测价值:一项系统评价和荟萃分析
Biomedicines. 2025 Feb 12;13(2):444. doi: 10.3390/biomedicines13020444.
3
Evaluation of Serum Soluble Lectin-like Oxidised Low-Density Lipoprotein Receptor-1 (sLOX-1) Level in Children with Non-Complicated Type-1 Diabetes Mellitus (T1DM) and Its Relationship with Carotid Intima Media Thickness (cIMT).

本文引用的文献

1
Distribution and Temporal Trends From 1993 to 2015 of Ischemic Stroke Subtypes: A Systematic Review and Meta-Analysis.1993 年至 2015 年缺血性脑卒中亚型的分布和时间趋势:系统评价和荟萃分析。
Stroke. 2018 Apr;49(4):814-819. doi: 10.1161/STROKEAHA.117.020031. Epub 2018 Mar 13.
2
Contribution of lectin-like oxidized low-density lipoprotein receptor-1 and LOX-1 modulating compounds to vascular diseases.凝集素样氧化型低密度脂蛋白受体-1及LOX-1调节化合物对血管疾病的作用
Vascul Pharmacol. 2017 Oct 19. doi: 10.1016/j.vph.2017.10.002.
3
LOX-1: A potential target for therapy in atherosclerosis; an in vitro study.
非复杂性1型糖尿病(T1DM)患儿血清可溶性凝集素样氧化低密度脂蛋白受体-1(sLOX-1)水平的评估及其与颈动脉内膜中层厚度(cIMT)的关系。
J Clin Med. 2025 Jan 31;14(3):935. doi: 10.3390/jcm14030935.
4
Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 (LOX-1): A Potential Therapeutic Target in Ischemic Stroke.凝集素样氧化型低密度脂蛋白受体-1(LOX-1):缺血性卒中的潜在治疗靶点。
Transl Stroke Res. 2024 Nov 22. doi: 10.1007/s12975-024-01307-z.
5
Novel Insights into the Link Between Myeloperoxidase Modified LDL, LOX-1, and Neuroserpin in Stroke.髓过氧化物酶修饰的低密度脂蛋白、凝集素样氧化型低密度脂蛋白受体1与神经丝氨酸蛋白酶在中风中的联系的新见解
Rev Cardiovasc Med. 2023 Dec 15;24(12):354. doi: 10.31083/j.rcm2412354. eCollection 2023 Dec.
6
Clinical Utility of Soluble Lectin Type Oxidized Low-Density Lipoprotein Receptor as a Biomarker for Myocardial Infarction and Stable Angina.可溶性凝集素型氧化低密度脂蛋白受体作为心肌梗死和稳定型心绞痛生物标志物的临床应用价值
Cureus. 2023 Dec 18;15(12):e50719. doi: 10.7759/cureus.50719. eCollection 2023 Dec.
7
Sex-specific association of visceral and subcutaneous adipose tissue volumes with systemic inflammation and innate immune cells in people living with obesity.肥胖人群内脏和皮下脂肪组织体积与全身炎症和固有免疫细胞的性别特异性关联。
Int J Obes (Lond). 2024 Apr;48(4):523-532. doi: 10.1038/s41366-023-01444-9. Epub 2023 Dec 22.
8
Elevated soluble LOX-1 predicts risk of first-time myocardial infarction.可溶性 LOX-1 水平升高预示首次心肌梗死的风险。
Ann Med. 2023;55(2):2296552. doi: 10.1080/07853890.2023.2296552. Epub 2023 Dec 22.
9
Novel Therapeutic Approaches to Prevent Atherothrombotic Ischemic Stroke in Patients with Carotid Atherosclerosis.新型治疗方法预防颈动脉粥样硬化患者的动脉粥样硬化血栓性缺血性脑卒中。
Int J Mol Sci. 2023 Sep 20;24(18):14325. doi: 10.3390/ijms241814325.
10
Serum Soluble Lectin-like Oxidized Low-Density Lipoprotein Receptor-1 (sLOX-1) Is Associated with Atherosclerosis Severity in Coronary Artery Disease.血清可溶性凝集素样氧化型低密度脂蛋白受体-1(sLOX-1)与冠状动脉疾病中的动脉粥样硬化严重程度相关。
Biomolecules. 2023 Jul 29;13(8):1187. doi: 10.3390/biom13081187.
凝集素样氧化低密度脂蛋白受体1:动脉粥样硬化治疗的潜在靶点;一项体外研究
Int J Biochem Cell Biol. 2017 Oct;91(Pt A):65-80. doi: 10.1016/j.biocel.2017.08.013. Epub 2017 Aug 30.
4
Mechanisms of erosion of atherosclerotic plaques.动脉粥样硬化斑块侵蚀的机制。
Curr Opin Lipidol. 2017 Oct;28(5):434-441. doi: 10.1097/MOL.0000000000000440.
5
LOX-1 in Atherosclerosis and Myocardial Ischemia: Biology, Genetics, and Modulation.LOX-1 在动脉粥样硬化和心肌缺血中的作用:生物学、遗传学和调控。
J Am Coll Cardiol. 2017 Jun 6;69(22):2759-2768. doi: 10.1016/j.jacc.2017.04.010.
6
Atherosclerotic plaque vulnerability in the statin era.他汀时代的动脉粥样硬化斑块易损性。
Eur Heart J. 2017 Jun 1;38(21):1638-1644. doi: 10.1093/eurheartj/ehx143.
7
Sphingolipids Contribute to Human Atherosclerotic Plaque Inflammation.鞘脂类物质促成人类动脉粥样硬化斑块炎症。
Arterioscler Thromb Vasc Biol. 2016 Jun;36(6):1132-40. doi: 10.1161/ATVBAHA.116.305675. Epub 2016 Apr 7.
8
High Levels of Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 in Acute Stroke: An Age- and Sex-Matched Cross-Sectional Study.急性卒中患者中可溶性凝集素样氧化低密度脂蛋白受体-1水平升高:一项年龄和性别匹配的横断面研究
J Atheroscler Thromb. 2016 Oct 1;23(10):1222-1226. doi: 10.5551/jat.32466. Epub 2016 Mar 29.
9
Inflammation and plaque vulnerability.炎症与斑块易损性
J Intern Med. 2015 Nov;278(5):483-93. doi: 10.1111/joim.12406. Epub 2015 Aug 11.
10
Requiem for the 'vulnerable plaque'.“易损斑块”的挽歌
Eur Heart J. 2015 Nov 14;36(43):2984-7. doi: 10.1093/eurheartj/ehv349. Epub 2015 Jul 22.